ATE152621T1 - Behandlungsverfahren kataboler dysfunktion - Google Patents

Behandlungsverfahren kataboler dysfunktion

Info

Publication number
ATE152621T1
ATE152621T1 AT86905644T AT86905644T ATE152621T1 AT E152621 T1 ATE152621 T1 AT E152621T1 AT 86905644 T AT86905644 T AT 86905644T AT 86905644 T AT86905644 T AT 86905644T AT E152621 T1 ATE152621 T1 AT E152621T1
Authority
AT
Austria
Prior art keywords
treatment methods
catabolic dysfunction
catabolic
dysfunction
animal
Prior art date
Application number
AT86905644T
Other languages
English (en)
Inventor
Douglas W Wilmore
Robert J Smith
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25103680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE152621(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE152621T1 publication Critical patent/ATE152621T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
AT86905644T 1985-09-12 1986-09-12 Behandlungsverfahren kataboler dysfunktion ATE152621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77521485A 1985-09-12 1985-09-12

Publications (1)

Publication Number Publication Date
ATE152621T1 true ATE152621T1 (de) 1997-05-15

Family

ID=25103680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86905644T ATE152621T1 (de) 1985-09-12 1986-09-12 Behandlungsverfahren kataboler dysfunktion

Country Status (8)

Country Link
EP (1) EP0238553B1 (de)
JP (1) JPH0794389B2 (de)
AT (1) ATE152621T1 (de)
AU (1) AU599335B2 (de)
CA (1) CA1285491C (de)
DE (1) DE3650620T2 (de)
DK (1) DK175711B1 (de)
WO (1) WO1987001589A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310768A (en) * 1987-10-29 1994-05-10 Ab Erik Vinnars Method for improving the glutamine content in skeletal muscle and composition therefore
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
SE8902544L (sv) * 1989-07-17 1991-01-18 Kabivitrum Ab Beredning foer naeringstillfoersel, samt saett foer dess framsaellning
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
IT1244880B (it) * 1990-12-11 1994-09-12 Torre A Farmaceutici Formulazioni di amminoacidi liofilizzati contenenti glutammina, loro preparazione ed uso nell'alimentazione parenterale
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5438075A (en) * 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
ES2070076B1 (es) * 1993-04-20 1996-04-16 Cusi Lab Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
DE69530570T2 (de) * 1994-01-11 2004-03-18 Stichting, Zofia Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
EP0875155A1 (de) * 1997-05-01 1998-11-04 N.V. Nutricia Perioperatives Getränk
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
JP4664071B2 (ja) 2002-08-01 2011-04-06 エーザイ コーポレーション オブ ノース アメリカ グルタミンによるガンの改良治療
BRPI0415480B1 (pt) * 2003-10-16 2019-09-17 Nestec S.A. Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia
JP5112865B2 (ja) 2005-06-27 2013-01-09 協和発酵バイオ株式会社 ヘモグロビン尿症またはミオグロビン尿症の予防または治療用組成物
WO2012040707A2 (en) 2010-09-24 2012-03-29 University Of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
KR20190040091A (ko) 2013-03-11 2019-04-16 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 폐 기능의 개선 및 방사선 유발된 폐 합병증의 예방 및/또는 치료를 위한 물질 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1909591A (en) * 1928-06-20 1933-05-16 Novocol Chemical Mfg Co Inc Method of utilizing hypodermic medicaments, etc.
US2868693A (en) * 1956-07-16 1959-01-13 Shive William Peptic ulcer-treating compositions containing glutamine
US3217711A (en) * 1963-08-01 1965-11-16 Abbott Lab Valve apparatus for sequentially administering parenteral fluid from separate sources
US3195778A (en) * 1963-09-17 1965-07-20 Alta Engineering Company Storage and mixing cartridge
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
US4200095A (en) * 1977-08-15 1980-04-29 Millipore Corporation Arrangement for intravenous administration or the like
US4265240A (en) * 1979-04-16 1981-05-05 Imed Corporation Apparatus for providing a controlled introduction of intravenous fluid to a patient
US4334535A (en) * 1980-08-12 1982-06-15 Cutter Laboratories, Inc. Conduit device for rapid priming and flow of liquid
SE8101247L (sv) * 1981-02-26 1982-08-27 Haessle Ab Lekemedelsadministrationsanordning
US4396383A (en) * 1981-11-09 1983-08-02 Baxter Travenol Laboratories, Inc. Multiple chamber solution container including positive test for homogenous mixture
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
JPS5927822A (ja) * 1982-08-05 1984-02-14 Kotobuki Seiyaku Kk 医療用組成物及びこの組成物を有効成分とする抗炎症抗潰瘍用剤

Also Published As

Publication number Publication date
EP0238553B1 (de) 1997-05-07
DK241287D0 (da) 1987-05-12
DE3650620D1 (de) 1997-06-12
DK175711B1 (da) 2005-01-31
DK241287A (da) 1987-07-10
JPH0794389B2 (ja) 1995-10-11
JPS63501214A (ja) 1988-05-12
DE3650620T2 (de) 1997-09-11
AU599335B2 (en) 1990-07-19
WO1987001589A1 (en) 1987-03-26
AU6337886A (en) 1987-04-07
EP0238553A1 (de) 1987-09-30
EP0238553A4 (de) 1990-03-08
CA1285491C (en) 1991-07-02

Similar Documents

Publication Publication Date Title
ATE152621T1 (de) Behandlungsverfahren kataboler dysfunktion
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DK90888D0 (da) Maaleapparat til vaevsmetabolisme
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE3587741T2 (de) Behandlung von Hautkrankheiten.
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE22659T1 (de) Verfahren zur behandlung der azyklie bei schafen oder rindern.
ATE149840T1 (de) Behandlung von leberkrebs
EA199800535A1 (ru) Способ лечения боли
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
DE3586197D1 (de) Verfahren zur reinigung sowie pasteurisierung von urokinase.
GB1538932A (en) Therapeutic method of treating mink infection and bovine mastitis by pseudomonas aeruginosa
DE3680140D1 (de) Behandlung von parasiterkrankungen.
PT86794A (pt) Process for the preparation of compositions for the treatment of wood and processes of treating wood
SU1051900A1 (ru) Способ получения полимерного препарата для лечения желудочно-кишечных заболеваний у животных
NO900044D0 (no) Hemorroidale, andre blandinger og metoder for behandling.
ATE5229T1 (de) Nasenspange zur prophylaktischen oder therapeutischen behandlung von rindern.
IT8741644A0 (it) Trasportatore allargatore di pelli da avviare alla lavora zione.
ATE44481T1 (de) Vorrichtung zur behandlung von werkstuecken.
ATE18888T1 (de) Vorrichtung zum behandeln von baeumen oder dergleichen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time